Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06078124
Other study ID # R34MH134078-01
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 1, 2024
Est. completion date August 31, 2025

Study information

Verified date October 2023
Source Washington University School of Medicine
Contact Ilana Seff, DrPH
Phone +14074638147
Email seff@wustl.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Forcibly displaced adolescents face increased risks for mental illness and distress, with adolescent girls disproportionately affected in part due to the heightened gender inequity that often accompanies forced displacement. Although the family unit has the potential to prevent mental illness and promote healthy development in adolescents, few family interventions have employed a gender transformative approach or included male siblings in an effort to maximize benefits for adolescent girls. Therefore, the investigators propose to assess an innovative whole-family and gender transformative intervention-Sibling Support for Adolescent Girls in Emergencies (SSAGE)-to prevent mental health disorders among adolescent girls in Colombia who were recently and forcibly displaced from Venezuela. The proposed R34 study will adapt the SSAGE curriculum through human-centered design with a range of stakeholders, including Venezuelan refugees, Colombian returnees and relevant civil society organizations. The proposed study will then employ a hybrid type 1 effectiveness-implementation pilot randomized control trial (RCT) to test the program's effectiveness and mechanistic pathways as well as to explore determinants of implementation in order to establish the feasibility, acceptability, and fidelity of SSAGE. To address these aims, the investigators will enroll 180 recently arrived, forcibly displaced adolescent girls in an RCT and examine the program's effectiveness on the prevention of mental illness (through reduction in anxiety, depression, interpersonal sensitivity, and somatization symptoms) one-month post-intervention. The investigators will use contextually adapted and piloted measures to collect additional data on the hypothesized mechanistic pathways, including family attachment, gender equitable family functioning, self-esteem, and coping strategies. The implementation evaluation will employ mixed methods to assess the program's feasibility, acceptability, fidelity and barriers and facilitators to successful implementation. Potential findings can support humanitarian program implementation, as well as inform policy to support adolescent girls' mental health and to prevent the myriad disorders that can arise as a result of exposure to displacement, conflict, and inequitable gender norms in their households and communities.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 180
Est. completion date August 31, 2025
Est. primary completion date April 30, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 13 Years to 19 Years
Eligibility Inclusion Criteria: - Live with a male and female caregiver and an adolescent male sibling or relative - Immigrated to Colombia within the last year - Are available, along with their family members, to participate in the SSAGE intervention for three months - Are available to participate in survey questionnaires immediately before and one month after the intervention Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Sibling Support for Adolescent Girls in Emergencies
The Sibling Support for Adolescent Girls in Emergencies (SSAGE) intervention is a gender-transformative, 12-week program utilizing a "whole family approach" wherein an adolescent girl, her male sibling, and a male and female caregiver participate in sessions that are age- and gender-specific and combined with family-wide discussions of session learnings. The sessions are interactive, engaging, and promote self-reflection and discussion on topics such as power, gender, interpersonal communication, and healthy relationships. Given the whole-family approach, SSAGE addresses intersections between spousal relationships, caregiver-child relationships, and relationships between siblings, as they pertain to supporting the mental health and psychosocial well-being of adolescent girls.

Locations

Country Name City State
n/a

Sponsors (5)

Lead Sponsor Collaborator
Washington University School of Medicine Mercy Corps, National Institutes of Health (NIH), Universidad de Los Andes, Women's Refugee Commission

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 Level 1 Cross-Cutting Symptom This measure includes 25 items and assesses the presence and severity of several psychiatric symptom domains including depression, anger, mania, anxiety, somatic symptoms, sleep disturbance, psychosis, obsessive thoughts and behaviors, suicidal thoughts and behaviors, substance use (e.g., alcohol, nicotine, prescription medication, and illicit substance use), inattention and irritability in children and adolescents. Nineteen of the items are rated on a 5-point scale (0=none/never; 1=slight/rare; 2=mild/several days; 3=moderate/more than half the days; and 4=severe/almost daily), where higher scores indicate higher frequency of occurrence or greater degree of severity. Questions on suicide ideation, suicide attempts, and substance use are rated on a 2-point scale of yes/no. Past two weeks
Primary Revised Children's Anxiety and Depression Scale (RCADS)-25 This scale assesses symptoms of depression and anxiety in children and adolescents using 25 items. Items are scored on a 4-point scale (0-never; 1-sometimes; 3-often; and 4-always). The total score is a sum of all item scores and can range from 0 to 100, with higher scores indicating more frequent/severe symptoms. Two subscales, representing depression and anxiety, can also be calculated. The Depression subscale can range from 0 to 40 and the Anxiety subscale can range from 0 to 60; for both subscales, higher scores indicate greater symptomology. Past two weeks
Secondary Family Attachment and Changeability Index (FACI-8) The FACI8 is a 16-item scale where each item is scored using a 5-point Likert scale of how frequently the event occurs (1-Never; 2-Sometimes; 3-Half of the time; 4-Most of the time; 5-Always). The FACI8 consists of two subscales: Attachment and Changeability. The eight items in the Attachment subscale are reverse coded and then summed to create a final score between 0 and 40, where higher scores reflect greater family attachment. The eight items in the Changeability suubscale are summed to create a final score between 0 to 40, where higher scores reflect greater flexibility of family relationships. Past two weeks
Secondary Rosenberg Self-Esteem Scale The Rosenberg Self-Esteem Scale is a 10-item scale that measures positive and negative feelngs about the self to create a measure of overall self-worth. Items are scored using a 4-point Likert scale signaling level of agreement with each statement, from strongly agree to strongly disagree. Five items are reverse coded. The final score can take a value from 10 to 40, with higher scores indicating greater self-esteem. Past two weeks
Secondary Kidcope Kidcope is a 15-item checklist designed to measure cognitive and behavioural coping in children and adolescents. It measures the frequency and efficacy of ten coping strategies, including: problem-solving, distraction, social support, social withdrawal, cognitive restructuring, self-criticism, blaming others, emotional expression, wishful thinking and resignation. Items related to frequency are scored on a 4-point scale (0 = "Not at all" to 3 = "Almost all the time"), and items related to effectiveness are scored on a 5-point scale (0 = "Not at all" to 4 = "Very much"). Higher scores on the healthy and most effective coping behaviors are better. A stressor that occurred in the last two weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A